We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+45.29%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$483M
AUM Growth
+$23M
(+5%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLX Energy Services
KLXE
|
+$3.31M |
| 2 |
Par Pacific Holdings
PARR
|
+$3.1M |
| 3 |
A10 Networks
ATEN
|
+$3.05M |
| 4 |
Federal Signal
FSS
|
+$2.71M |
| 5 |
Tidewater
TDW
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.93M |
| 2 |
Cogent Biosciences
COGT
|
+$5.04M |
| 3 |
Lantheus
LNTH
|
+$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
+$4.1M |
| 5 |
Cytokinetics
CYTK
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.48% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Old Second Bancorp
OSBC
$1.3B
| $969K | 0.2% |
+60,426
| New | +$966K |
|
227
Post Holdings
POST
$3.57B
| $959K | 0.2% |
10,630
-8,235
| -44% | -$734K |
|
228
Array Technologies
ARRY
$855M
| $944K | 0.2% |
48,852
-20,117
| -29% | -$382K |
|
229
Murphy Oil
MUR
$4.78B
| $937K | 0.19% |
+21,796
| New | +$982K |
|
230
Murphy USA
MUSA
$9.61B
| $935K | 0.19% |
3,345
-1,400
| -30% | -$406K |
|
231
TriCo Bancshares
TCBK
$1.83B
| $929K | 0.19% |
+18,221
| New | +$951K |
|
|
KRTX
232
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $928K | 0.19% |
4,723
-4,022
| -46% | -$862K |
|
233
United Bankshares
UBSI
$6.62B
| $915K | 0.19% |
+22,604
| New | +$916K |
|
234
Kinsale Capital Group
KNSL
$8.51B
| $901K | 0.19% |
3,446
-4,496
| -57% | -$1.3M |
|
235
Syndax Pharmaceuticals
SNDX
$1.82B
| $901K | 0.19% |
35,391
-16,777
| -32% | -$391K |
|
236
Cohu
COHU
$2.5B
| $891K | 0.18% |
+27,786
| New | +$899K |
|
237
Banner Corp
BANR
$2.4B
| $889K | 0.18% |
+14,060
| New | +$944K |
|
238
1st Source
SRCE
$2.12B
| $884K | 0.18% |
+16,653
| New | +$907K |
|
239
HF Sinclair
DINO
$14.5B
| $864K | 0.18% |
16,653
-4,081
| -20% | -$235K |
|
240
Amalgamated Financial
AMAL
$1.49B
| $863K | 0.18% |
37,471
-26,167
| -41% | -$634K |
|
241
Viemed Healthcare
VMD
$371M
| $842K | 0.17% |
111,031
| – | – |
|
|
NUVL
242
DELISTED
Nuvalent
NUVL
| $827K | 0.17% |
+27,754
| New | +$774K |
|
243
City Holding Co
CHCO
$2.04B
| $814K | 0.17% |
+8,743
| New | +$842K |
|
244
Universal Logistics Holdings
ULH
$529M
| $748K | 0.15% |
22,361
-10,620
| -32% | -$372K |
|
|
INBX
245
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $745K | 0.15% |
+30,240
| New | +$889K |
|
|
HTBK
246
DELISTED
Heritage Commerce
HTBK
| $726K | 0.15% |
+55,846
| New | +$751K |
|
247
Frontline
FRO
$8.85B
| $720K | 0.15% |
59,300
-50,016
| -46% | -$642K |
|
248
Stabilis Solutions
SLNG
$87.2M
| $609K | 0.13% |
+117,597
| New | +$847K |
|
|
BLU
249
DELISTED
BELLUS Health Inc.
BLU
| $164K | 0.03% |
20,039
-78,026
| -80% | -$728K |
|
250
Applied Optoelectronics
AAOI
$10.9B
| – | – |
-489,680
| Closed | -$1.33M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q4 2022 Portfolio in Review
As of Q4 2022, EAM Investors held 378 positions worth $483M, up 5% from $460M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
EAM Investors withdrew a net $62.1M in Q4 2022, closing 129 positions and reducing 97 holdings. Its most notable exit was Concert Pharmaceuticals, Inc., an estimated $5.93M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.
Against the trend, EAM Investors opened a new position in KLX Energy Services worth $4.07M.
- EAM Investors's largest Q4 2022 buy was KLX Energy Services: 234,913 shares worth $4.07M.
- EAM Investors added most to Modine Manufacturing in Q4 2022, an estimated $1.28M increase.
- EAM Investors's biggest Q4 2022 reduction was Aehr Test Systems, cutting an estimated $3.09M.
- EAM Investors fully exited Concert Pharmaceuticals, Inc. in Q4 2022, selling an estimated $5.93M.
- EAM Investors's ten largest holdings make up 9.9% of its $483M portfolio in Q4 2022.
- EAM Investors opened 132 new positions and closed 129 in Q4 2022.
- EAM Investors's portfolio value rose 5% quarter-over-quarter to $483M.
Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.